☆ 4.5 Review

Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights

BRAIN RESEARCH BULLETIN (2023)

Related references

Note: Only part of the references are listed.

Review Medicine, Research & Experimental

Anti-inflammatory action of astaxanthin and its use in the treatment of various diseases

Zeynab Kohandel et al.

Summary: This study summarizes the anti-inflammatory efficacy of astaxanthin in various chronic and acute disorders, as well as the pathways through which it mediates its effects. Further experimental and clinical studies are needed to confirm the anti-inflammatory and protective effects of astaxanthin in humans. The review suggests that astaxanthin, with its demonstrated anti-inflammatory properties, may be a suitable candidate for drug design with novel technology.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Carotenoids from Marine Sources as a New Approach in Neuroplasticity Enhancement

Sylwia Pietrasik et al.

Summary: Neuroplasticity plays a crucial role in the treatment of central nervous system (CNS) disorders, and marine carotenoids, abundant in the aquatic environment, have antioxidant and neuroprotective effects that can promote neuronal recovery and enhancement.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Chemistry, Medicinal

Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents

Elisabete Lima et al.

Summary: Marine organisms synthesize various compounds to defend themselves and some of these compounds may have neuroprotective effects. Alzheimer's disease is a complex disease with both genetic and environmental factors, and there is currently no effective treatment. Alkaloids, particularly those with planar structures, halogens, and amine quaternization, may be used against Alzheimer's by reducing its clinical manifestations.

MARINE DRUGS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Astaxanthin as a Modulator of Nrf2, NF-κB, and Their Crosstalk: Molecular Mechanisms and Possible Clinical Applications

Sergio Davinelli et al.

Summary: This article reviews the potential molecular mechanisms by which astaxanthin (AST) regulates the transcription factors Nrf2 and NF-κB, which are involved in oxidative stress and inflammation. Additionally, it summarizes the current clinical studies elucidating how AST alleviates the etiopathogenesis of oxidative stress and inflammation.

MOLECULES (2022)

Add to Collection

Review Pharmacology & Pharmacy

Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases

Manel Dhahri et al.

Summary: Neurodegenerative diseases pose a significant public health burden globally, particularly among aging populations. Despite advances in understanding the underlying mechanisms, effective therapeutic strategies are lacking. Natural polysaccharides have shown neuroprotective and therapeutic effects, making them a potential avenue for prevention and treatment of neurodegenerative diseases.

PHARMACEUTICS (2022)

Add to Collection

Review Cell Biology

Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform

Miguel Pinto et al.

Summary: Effective drugs for the treatment of neurodegenerative disorders remain a challenge, but the advancement of nanotechnology and nanomedicine offers potential solutions. Polymeric nanoparticles, particularly based on PLGA, have shown success in treating cancer and other diseases, but further research is needed for neurodegenerative disorders.

AGEING RESEARCH REVIEWS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Pathogenic mechanisms and therapeutic promise of phytochemicals and nanocarriers based drug delivery against radiotherapy-induced neurotoxic manifestations

Ashif Iqubal et al.

Summary: Radiotherapy is commonly used to treat glioblastoma and other types of cancers, but it can cause neuroinflammation and cognitive dysfunction. Various drugs and nanocarrier systems have been explored to mitigate these side effects, but limitations still exist. Therefore, researchers are investigating the neuroprotective potential and mechanisms of other natural products and miRNAs.

DRUG DELIVERY (2022)

Add to Collection

Article Chemistry, Medicinal

Simultaneous Inhibitory Effects of All-Trans Astaxanthin on Acetylcholinesterase and Oxidative Stress

Xin Wang et al.

Summary: All-trans astaxanthin, derived mainly from marine organisms, showed a strong inhibitory effect on acetylcholinesterase and oxidative stress. It acted as a reversible competitive inhibitor with a half inhibitory concentration (IC50 value) of 8.64 mu mol/L. Additionally, all-trans astaxanthin reduced oxidative stress by decreasing malondialdehyde content and increasing the activity of superoxide dismutase and catalase. It also induced changes in the secondary structure of acetylcholinesterase to reduce its activity. Molecular-docking analysis revealed that all-trans astaxanthin prevented substrate binding to acetylcholinesterase by occupying the active pocket space.

MARINE DRUGS (2022)

Add to Collection

Review Chemistry, Medicinal

A Systematic Review on Marine Algae-Derived Fucoxanthin: An Update of Pharmacological Insights

Md. Mohibbullah et al.

Summary: Fucoxanthin, a natural antioxidant pigment found in marine algae, has potential benefits for human health and disease management. It has attracted significant attention from the scientific community but more clinical research is needed.

MARINE DRUGS (2022)

Add to Collection

Review Nutrition & Dietetics

Astaxanthin Bioactivity Is Determined by Stereoisomer Composition and Extraction Method

Terry W. Snell et al.

Summary: Astaxanthin (ASX) is a powerful antioxidant that has significant effects on the metabolism of many animals, increasing reproductive capacity, egg yolk volume, growth rates, immune responses, and disease resistance. ASX targets mitochondria to protect them from damage by reactive oxygen species (ROS). Most animals cannot synthesize ASX and need to acquire it from their diet. However, ASX is easily denatured during extraction and its hydrophobicity limits its bioavailability.

NUTRIENTS (2022)

Add to Collection

Article Genetics & Heredity

Nrf2/HO-1 Signaling Stimulation through Acetyl-11-keto-beta-boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis

Shubham Upadhayay et al.

Summary: This study investigates the protective potential of AKBA on multiple sclerosis (MS) and found that AKBA can upregulate antioxidant proteins, restore neurochemical abnormalities, and potentially prevent pathological changes in MS.

GENES (2022)

Add to Collection

Article Multidisciplinary Sciences

Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer's disease

Hormoz Pourtaher et al.

Summary: This study aimed to design new polysubstituted pyrrole derivatives as selective acetylcholinesterase inhibitors for Alzheimer's disease treatment. A diverse range of polysubstituted pyrroles was synthesized through a sequential domino strategy, and compound 4ad showed the highest potency and selectivity against acetylcholinesterase. The compound inhibited acetylcholinesterase in an uncompetitive mode, and molecular modeling revealed its proper fit and stabilization in the enzyme's active site.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer's disease

Nasimudeen R. Jabir et al.

Summary: This study identified ligands that effectively bind to two protein targets associated with Alzheimer's disease using advanced computational biology tools. Among 100 ligands screened, 48 were found to have promising binding energy profiles, and 13 were selected based on their blood brain barrier permeability, acceptable ADME properties, and molecular interaction profiles with the AD targets. Further wet laboratory validation is needed to confirm the effectiveness of these selected ligands for future AD treatment.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Article Neurosciences

Astaxanthin Improved the Cognitive Deficits in APP/PS1 Transgenic Mice Via Selective Activation of mTOR

Cuiqin Huang et al.

Summary: Astaxanthin can improve cognitive deficits in AD mice by activating the mTOR pathway, leading to enhanced learning and memory capabilities.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)

Add to Collection

Article Chemistry, Medicinal

Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents

Mina Saeedi et al.

Summary: This study focused on developing novel compounds targeting Alzheimer's disease by inhibiting AChE and BuChE, with compound 4e showing the best inhibitory effects. Molecular docking studies revealed strong interactions between 4e and key residues in AChE and BuChE active sites. Overall, compound 4e demonstrated promising potential in targeting multiple factors associated with AD.

ARCHIV DER PHARMAZIE (2021)

Add to Collection

Article Medicine, Research & Experimental

Dieckol: a brown algal phlorotannin with biological potential

Durairaj Karthick Rajan et al.

Summary: Dieckol, a natural phlorotannin found in brown algal species, exhibits various therapeutic functions such as antibacterial, anticancer, and antioxidant properties. It plays a significant role in inducing apoptosis by inhibiting certain signaling molecules and inhibits lipid accumulation in animal models. Dieckol shows potential as a pharmaceutical compound for treating multiple diseases.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Review Pharmacology & Pharmacy

Role of reactive oxygen species in the progression of Alzheimer's disease

Shvetank Bhatt et al.

Summary: The pathogenesis of Alzheimer's disease involves neurodegeneration, with oxidative stress being a key detrimental factor. Antioxidants have therapeutic effects in preventing and delaying the progression of AD pathology.

DRUG DISCOVERY TODAY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer's Treatment: A Computational Strategy

Nasimudeen R. Jabir et al.

Summary: With the growing global aging population, the incidence of Alzheimer's disease (AD) and related disorders is increasing. In this study, 13 ligands were screened for targeting 3 different enzymes, showing 8 ligands with binding energies of <= -8.0 kcal/mol towards BChE, MAO-A and MAO-B. The ligand 6Z5 was identified as the most potent inhibitor of BChE and MAO-B.

CURRENT PHARMACEUTICAL DESIGN (2021)

Add to Collection

Article Cell Biology

Astaxanthin-Mediated Bacterial Lethality: Evidence from Oxidative Stress Contribution and Molecular Dynamics Simulation

Jamiu Olaseni Aribisala et al.

Summary: The study evaluated the role of oxidative stress in astaxanthin-mediated antibacterial action through both in silico and in vitro analyses. Results suggest that oxidative stress may be involved in the antibacterial mechanism of astaxanthin, as evidenced by the increase in superoxide anion levels in tested organisms following treatment with astaxanthin. The higher free energy scores of astaxanthin's complexes with topoisomerase IV ParC and ParE compared to reference antibiotics indicate a potential role of oxidative stress in the antibacterial capability of astaxanthin.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Add to Collection

Article Cell Biology

Ameliorative effects of astaxanthin on brain tissues of alzheimer's disease-like model: cross talk between neuronal-specific microRNA-124 and related pathways

Hala A. Hafez et al.

Summary: This study demonstrated that astaxanthin (ATX) has a promising therapeutic effect on Alzheimer's disease by improving cognitive function, suppressing amyloid accumulation, regulating enzyme and protein expressions, and targeting different pathogenic pathways.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization

Debora Santonocito et al.

Summary: Alzheimer's disease is a neurodegenerative disorder associated with oxidative stress in the brain, and increasing antioxidant capacity could be a promising therapeutic strategy. Astaxanthin-loaded stealth lipid nanoparticles (AST-SSLNs) have been developed to improve AST bioavailability in the brain, showing potential as effective carriers for systemic administration targeted at AD treatment.

NANOMATERIALS (2021)

Add to Collection

Review Food Science & Technology

Phlorotannins: A review on biosynthesis, chemistry and bioactivity

S. Shrestha et al.

Summary: Phlorotannins are polyphenolic compounds mainly found in brown seaweed, with a range of bioactivities including neuroprotective, antidiabetic, anticancer properties. Current research is mainly based on biochemical and cell-based assays, highlighting the need for further preclinical and clinical studies to investigate their bioavailability, efficacy and safety.

FOOD BIOSCIENCE (2021)

Add to Collection

Review Medicine, Research & Experimental

Nrf2 a molecular therapeutic target for Astaxanthin

Zeynab Kohandel et al.

Summary: Astaxanthin (ATX) is a red pigment carotenoid found in shrimp, salmon, crab, and asteroidean, with proven antioxidant efficacy. Nrf2 plays a crucial role in mediating the various protective effects of ATX.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Article Chemistry, Physical

Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents

Mina Saeedi et al.

Summary: A new series of methylindolinone-1,2,3-triazole derivatives were synthesized and evaluated for their cholinesterase inhibitory activity, with compound 7k showing more potent activity against BuChE than the reference drug donepezil. Molecular docking evaluation revealed that compound 7k could bind simultaneously to the peripheral and catalytic sites of BuChE, indicating its potential as a neuroprotective agent.

JOURNAL OF MOLECULAR STRUCTURE (2021)

Add to Collection

Article Chemistry, Physical

Synthesis and biological activity of pyrimidines-containing hybrids: Focusing on pharmacological application

Elham Zarenezhad et al.

Summary: Heterocyclic derivatives are widely used in pharmaceutical and industrial applications, known for their biological and pharmacological properties. Among them, pyrimidine compounds have attracted attention for their substructures in therapeutic products. The potential therapeutic properties of these heterocycles have inspired the synthesis of novel chemotherapeutic agents by medicinal chemists.

JOURNAL OF MOLECULAR STRUCTURE (2021)

Add to Collection

Review Chemistry, Medicinal

Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances

Md Ataur Rahman et al.

Summary: Marine sterols have shown potential in combating Alzheimer's disease, with their anti-inflammatory and antioxidant properties providing various health benefits, including anti-aging and anti-cancer effects. Through interactions with different proteins and enzymes, marine sterols participate in regulating multiple cellular systems.

MARINE DRUGS (2021)

Add to Collection

Review Chemistry, Medicinal

Marine Natural Products: Promising Candidates in the Modulation of Gut-Brain Axis towards Neuroprotection

Sajad Fakhri et al.

Summary: Research in recent years has highlighted the importance of the gut-brain axis in the prevention, management, and treatment of neurodegenerative diseases, suggesting a potential new approach in using marine-derived natural products for neuroprotection.

MARINE DRUGS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches

Pedro Cruz-Vicente et al.

Summary: Neurodegenerative diseases such as Alzheimer's and Parkinson's Disease are increasing in prevalence and pose a significant social issue. Current treatments aim at symptom relief rather than stopping disease progression. The use of in silico approaches for drug development shows promising prospects for future treatments.

MOLECULES (2021)

Add to Collection

Review Pharmacology & Pharmacy

Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials

Andrea Donoso et al.

Summary: Astaxanthin is a natural antioxidant with various health benefits, such as neuroprotection, cardioprotection, anti-tumoral properties, and promotion of skin and eye health. Studies have shown that astaxanthin has higher antioxidant and free radical inhibitory activity compared to other antioxidants, suggesting its significant potential for disease prevention.

PHARMACOLOGICAL RESEARCH (2021)

Add to Collection

Article Neurosciences

The effects of astaxanthin treatment on a rat model of Alzheimer's disease

Mu-Hsuan Chen et al.

Summary: Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss and dementia, potentially caused by abnormalities in cortical milieu and protein aggregation. Results indicate that astaxanthin may help slow the progression of the disease by reducing neuroinflammation, restoring neuronal fibers, and improving hippocampal neuron morphology.

BRAIN RESEARCH BULLETIN (2021)

Add to Collection

Article Neurosciences

A current view on Tau protein phosphorylation in Alzheimer's disease

Susanne Wegmann et al.

Summary: The functions of Tau in the central nervous system are regulated by various posttranslational modifications, with phosphorylation being widely recognized as a pathological hallmark in diseases like AD. However, the similarities and heterogeneity of phosphorylation patterns between physiological and pathological Tau make it challenging to identify specific modifications as therapeutic targets and biomarkers.

CURRENT OPINION IN NEUROBIOLOGY (2021)

Add to Collection

Article Agriculture, Multidisciplinary

PLGA-PEG Nanoparticles Facilitate In Vivo Anti-Alzheimer's Effects of Fucoxanthin, a Marine Carotenoid Derived from Edible Brown Algae

Mengxiang Yang et al.

Summary: Studies have shown that nanoscale PLGA-PEG-Fuc particles can improve the bioavailability of fucoxanthin, inhibit the formation of Aβ fibers and oligomers, reduce Aβ oligomer-induced neurotoxicity, and effectively prevent cognitive impairments in AD mice.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

Add to Collection

Article Chemistry, Medicinal

Mixture of Phlorotannin and Fucoidan from Ecklonia cava Prevents the Aβ-Induced Cognitive Decline with Mitochondrial and Cholinergic Activation

Hye Ju Han et al.

Summary: The mixture P4F6 showed a potential anti-amnesic effect on A beta-induced cognitive deficit mice by reducing oxidative stress, enhancing mitochondrial function, regulating tau hyperphosphorylation, promoting BDNF expression, and improving cholinergic system function.

MARINE DRUGS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors

Tapan Behl et al.

Summary: Despite being less utilized in depression treatment compared to other antidepressants, monoamine oxidase inhibitors (MAOIs) have shown potential in neuroprotection and treatment of neurological and psychiatric conditions. Research on MAOIs, particularly on their neuroprotective activities, has been progressing, indicating a possible role in conditions like Alzheimer's disease. The therapeutic potential of MAOIs, especially in neurodegenerative diseases, suggests a promising future for these drugs with a better understanding of their physiology.

MOLECULES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease

Vyshnavy Balendra et al.

Summary: Oxidative stress leads to neurotoxic protein accumulation in AD, while antioxidants like SOD and AST can prevent cognitive decline and reduce plaque burden in mice.

OPEN BIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer's treatment

Nasimudeen R. Jabir et al.

Summary: Virtual screening, molecular docking, and molecular dynamics simulation studies have revealed the potential of these multi-enzyme targeted ligands. Among the studied ligands, 6Z5 appears to have the best binding potential and forms a stable complex with BACE-1 and gamma-secretase. We recommend the synthesis of 6Z5 for future in vitro and in vivo studies.

ANNALS OF MEDICINE (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Regulation of divalent metal ions to the aggregation and membrane damage of human islet amyloid polypeptide oligomers

Yajie Wang et al.

Summary: This study reveals the significant role of divalent metal ions in the aggregation and cytotoxicity of hIAPP, with metal-associated hIAPP oligomers showing reduced ability to damage lipid membranes. The interaction between metal ions and hIAPP oligomers can affect the extent of membrane damage, depending on the peptide-to-metal ratio. Additionally, the abundance of oligomer species with altered disruptive ability can influence the membrane damage caused by hIAPP oligomers.

RSC ADVANCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer's disease modifying agents

Mahnaz Yazdani et al.

MOLECULAR DIVERSITY (2020)

Add to Collection

Article Chemistry, Applied

Encapsulation of fucoxanthin in binary matrices of porous starch and halloysite

Najme Oliyaei et al.

FOOD HYDROCOLLOIDS (2020)

Add to Collection

Review Chemistry, Medicinal

Marine Biocompounds for Neuroprotection-A Review

Adrian Florian Balasa et al.

MARINE DRUGS (2020)

Add to Collection

Article Microbiology

The Microbiota-Gut-Brain Axis-Heart Shunt Part II: Prosaic Foods and the Brain-Heart Connection in Alzheimer Disease

Mark Obrenovich et al.

MICROORGANISMS (2020)

Add to Collection

Review Clinical Neurology

The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics

Sarah A. Kent et al.

ACTA NEUROPATHOLOGICA (2020)

Add to Collection

Article Nanoscience & Nanotechnology

Dual Effect of the Acidic Polysaccharose Ulvan on the Inhibition of Amyloid-β Protein Fibrillation and Disintegration of Mature Fibrils

Fufeng Liu et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

Add to Collection

Article Medicine, Legal

Safety assessment of astaxanthin from Haematococcus pluvialis: Acute toxicity, genotoxicity, distribution and repeat-dose toxicity studies in gestation mice

Tingting Niu et al.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)

Add to Collection

Review Immunology

Alzheimer's disease: natural products as inhibitors of neuroinflammation

Olumayokun A. Olajide et al.

INFLAMMOPHARMACOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Fucoxanthin, a Marine-Derived Carotenoid from Brown Seaweeds and Microalgae: A Promising Bioactive Compound for Cancer Therapy

Sarah Meresse et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease

Hajar Karimi Askarani et al.

BMC CHEMISTRY (2020)

Add to Collection

Review Chemistry, Medicinal

Pharmacokinetics of Marine-Derived Drugs

Alexander N. Shikov et al.

MARINE DRUGS (2020)

Add to Collection

Article Chemistry, Medicinal

Fucoxanthin Attenuates Behavior Deficits and Neuroinflammatory Response in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease in Mice

Guoqing Sun et al.

PHARMACOGNOSY MAGAZINE (2020)

Add to Collection

Article Medicine, Research & Experimental

Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease

Syed Obaidur Rahman et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Astaxanthin induces apoptosis and increases activity of antioxidant enzymes in LS-180 cells

Maryam Hormozi et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)

Add to Collection

Review Chemistry, Multidisciplinary

Metal Ions in Alzheimer's Disease: A Key Role or Not?

Yan Liu et al.

ACCOUNTS OF CHEMICAL RESEARCH (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Anti-Inflammatory Activities of Marine Algae in Neurodegenerative Diseases

Maria Cristina Barbalace et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Review Chemistry, Medicinal

Multi-target design strategies for the improved treatment of Alzheimer's disease

Pengfei Zhang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Review Neurosciences

The neuropathological diagnosis of Alzheimer's disease

Michael A. DeTure et al.

MOLECULAR NEURODEGENERATION (2019)

Add to Collection

Article Neurosciences

Receptor-Mediated Delivery of Astaxanthin-Loaded Nanoparticles to Neurons: An Enhanced Potential for Subarachnoid Hemorrhage Treatment

Zong-qi You et al.

FRONTIERS IN NEUROSCIENCE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis

Johant Lakey-Beitia et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer's Disease

Huan Wang et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Design and Synthesis of Selective Acetylcholinesterase Inhibitors: Arylisoxazole-Phenylpiperazine Derivatives

Mina Saeedi et al.

CHEMISTRY & BIODIVERSITY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ1-42) toxicity and aggregation

Mousa Alghazwi et al.

NEUROCHEMISTRY INTERNATIONAL (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease

Aida Iraji et al.

BIOORGANIC CHEMISTRY (2018)

Add to Collection

Review Clinical Neurology

The cholinergic system in the pathophysiology and treatment of Alzheimer's disease

Harald Hampel et al.

BRAIN (2018)

Add to Collection

Review Cell Biology

Tau Proteins and Tauopathies in Alzheimer's Disease

Fong Ping Chong et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)

Add to Collection

Review Neurosciences

Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease

Nasimudeen R. Jabir et al.

CNS NEUROSCIENCE & THERAPEUTICS (2018)

Add to Collection

Article Biochemistry & Molecular Biology

α-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson's disease

Seong Su Kang et al.

EMBO JOURNAL (2018)

Add to Collection

Article Chemistry, Applied

Fucoxanthin bioavailability from fucoxanthin-fortified milk: In vivo and in vitro study

Il-Kyoon Mok et al.

FOOD CHEMISTRY (2018)

Add to Collection

Article Agriculture, Multidisciplinary

Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice

Hongxia Che et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)

Add to Collection

Article Nutrition & Dietetics

Effect of astaxanthin-rich extract derived from Paracoccus carotinifaciens on cognitive function in middle-aged and older individuals

Masahiro Hayashi et al.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2018)

Add to Collection

Article Nutrition & Dietetics

Effects of Dietary Supplementation of Astaxanthin and Sesamin on Daily Fatigue: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study

Ayano Imai et al.

NUTRIENTS (2018)

Add to Collection

Review Chemistry, Medicinal

On the Neuroprotective Role of Astaxanthin: New Perspectives?

Christian Galasso et al.

MARINE DRUGS (2018)

Add to Collection

Article Clinical Neurology

Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status

Hilda Ferrero et al.

CNS DRUGS (2017)

Add to Collection

Review Chemistry, Medicinal

Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease

Qi Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Add to Collection

Article Chemistry, Medicinal

Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis

Sara Azimi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Add to Collection

Article Chemistry, Medicinal

Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease

Aida Iraji et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Management of Alzheimer's disease-An insight of the enzymatic and other novel potential targets

Badar ul Islam et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)

Add to Collection

Article Agriculture, Multidisciplinary

Fucoxanthin Inhibits β-Amyloid Assembly and Attenuates β-Amyloid Oligomer-Induced Cognitive Impairments

Siying Xiang et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)

Add to Collection

Article Chemistry, Medicinal

Protective Effects of Fucoidan on A25-35 and d-Gal-Induced Neurotoxicity in PC12 Cells and d-Gal-Induced Cognitive Dysfunction in Mice

Hengyun Wei et al.

MARINE DRUGS (2017)

Add to Collection

Article Cell Biology

Fucoxanthin, a Marine Carotenoid, Attenuates beta-Amyloid Oligomer-Induced Neurotoxicity Possibly via Regulating the PI3K/Akt and the ERK Pathways in SH-SY5Y Cells

Jiajia Lin et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Add to Collection

Article Food Science & Technology

Fucoxanthin prevents H2O2-induced neuronal apoptosis via concurrently activating the PI3-K/Akt cascade and inhibiting the ERK pathway

Jie Yu et al.

FOOD & NUTRITION RESEARCH (2017)

Add to Collection

Article Neurosciences

Mast Cell Activation in Brain Injury, Stress, and Post-traumatic Stress Disorder and Alzheimer's Disease Pathogenesis

Duraisamy Kempuraj et al.

FRONTIERS IN NEUROSCIENCE (2017)

Add to Collection

Article Chemistry, Medicinal

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation

Anna Wieckowska et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Add to Collection

Article Food Science & Technology

Kinetics and molecular docking studies of fucosterol and fucoxanthin, BACE1 inhibitors from brown algae Undaria pinnatifida and Ecklonia stolonifera

Hyun Ah Jung et al.

FOOD AND CHEMICAL TOXICOLOGY (2016)

Add to Collection

Article Chemistry, Medicinal

Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in Vitro

Jiajia Lin et al.

MARINE DRUGS (2016)

Add to Collection

Review Clinical Neurology

Toxic species in amyloid disorders: Oligomers or mature fibrils

Meenakshi Verma et al.

ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2015)

Add to Collection

Article Chemistry, Medicinal

N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological Evaluation

Najmeh Edraki et al.

ARCHIV DER PHARMAZIE (2015)

Add to Collection

Article Chemistry, Medicinal

Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry

Yiping Zhang et al.

MARINE DRUGS (2015)

Add to Collection

Review Chemistry, Medicinal

Anti-Obesity Activity of the Marine Carotenoid Fucoxanthin

Maria Alessandra Gammone et al.

MARINE DRUGS (2015)

Add to Collection

Article Neurosciences

NEUROPROTECTIVE EFFECT OF ASTAXANTHIN AGAINST GLUTAMATE-INDUCED CYTOTOXICITY IN HT22 CELLS: INVOLVEMENT OF THE Akt/GSK-3β PATHWAY

X. Wen et al.

NEUROSCIENCE (2015)

Add to Collection

Review Pharmacology & Pharmacy

Microglial dysfunction in brain aging and Alzheimer's disease

Kira Irving Mosher et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Add to Collection

Review Pharmacology & Pharmacy

Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers

Christiane Reitz et al.

BIOCHEMICAL PHARMACOLOGY (2014)

Add to Collection

Article Pharmacology & Pharmacy

Serotonergic Therapies for Cognitive Symptoms in Alzheimer's Disease: Rationale and Current Status

Maria J. Ramirez et al.

DRUGS (2014)

Add to Collection

Article Food Science & Technology

Antioxidant activity and phenolic content of pressurised liquid and solid-liquid extracts from four Irish origin macroalgae

Natalie Heffernan et al.

INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY (2014)

Add to Collection

Review Chemistry, Medicinal

Bioactive Compounds from Macroalgae in the New Millennium: Implications for Neurodegenerative Diseases

Mariana Barbosa et al.

MARINE DRUGS (2014)

Add to Collection

Review Biochemistry & Molecular Biology

Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation

Francis Hane et al.

BIOMOLECULES (2014)

Add to Collection

Article Biochemistry & Molecular Biology

The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers

Nadine D. Younan et al.

FASEB JOURNAL (2013)

Add to Collection

Review Chemistry, Medicinal

Anti-diabetic effects of brown algae derived phlorotannins, marine polyphenols through diverse mechanisms

Seung-Hong Lee et al.

FITOTERAPIA (2013)

Add to Collection

Article Agriculture, Multidisciplinary

Benefits of using algae as natural sources of functional ingredients

Elena Ibanez et al.

JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2013)

Add to Collection

Review Chemistry, Medicinal

Beneficial Effects of Marine Algal Compounds in Cosmeceuticals

Noel Vinay Thomas et al.

MARINE DRUGS (2013)

Add to Collection

Article Medicine, General & Internal

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

Thorlakur Jonsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Article Nutrition & Dietetics

Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract

Takashi Hashimoto et al.

BRITISH JOURNAL OF NUTRITION (2012)

Add to Collection

Article Nutrition & Dietetics

Effects of astaxanthin-rich Haematococcus pluvialis extract on cognitive function: a randomised, double-blind, placebo-controlled study

Mikiyuki Katagiri et al.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2012)

Add to Collection

Review Food Science & Technology

Seaweeds: A sustainable functional food for complementary and alternative therapy

Suhaila Mohamed et al.

TRENDS IN FOOD SCIENCE & TECHNOLOGY (2012)

Add to Collection

Article Chemistry, Applied

Anti-proliferative and potential anti-diabetic effects of phenolic-rich extracts from edible marine algae

Felix Nwosu et al.

FOOD CHEMISTRY (2011)

Add to Collection

Article Food Science & Technology

Effect of a commercially-available algal phlorotannins extract on digestive enzymes and carbohydrate absorption in vivo

Marie-Claude Roy et al.

FOOD RESEARCH INTERNATIONAL (2011)

Add to Collection

Article Biochemistry & Molecular Biology

Aluminum, copper, iron and zinc differentially alter amyloid-Aβ1-42 aggregation and toxicity

Silvia Bolognin et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)

Add to Collection

Article Pharmacology & Pharmacy

Discovery of Histamine H-3 Antagonists for the Treatment of Cognitive Disorders and Alzheimer's Disease

Jorge D. Brioni et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)

Add to Collection

Review Neurosciences

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

Berislav V. Zlokovic

NATURE REVIEWS NEUROSCIENCE (2011)

Add to Collection

Article Pharmacology & Pharmacy

Pharmacotherapeutic Approaches of Parkinson’s Disease

J.A. Ansari et al.

International Journal of Pharmacology (2010)

Add to Collection

Article Nutrition & Dietetics

Keto-Carotenoids Are the Major Metabolites of Dietary Lutein and Fucoxanthin in Mouse Tissues

Lina Yonekura et al.

JOURNAL OF NUTRITION (2010)

Add to Collection

Article Cell Biology

Metals, oxidative stress and neurodegenerative disorders

Klaudia Jomova et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)

Add to Collection

Article Nutrition & Dietetics

The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice

Takashi Hashimoto et al.

BRITISH JOURNAL OF NUTRITION (2009)

Add to Collection

Review Biochemistry & Molecular Biology

Copper and Zinc Binding to Amyloid-β: Coordination, Dynamics, Aggregation, Reactivity and Metal-Ion Transfer

Peter Faller

CHEMBIOCHEM (2009)

Add to Collection

Article Agriculture, Multidisciplinary

Inhibitory Effects and Molecular Mechanism of Dieckol Isolated from Marine Brown Alga on COX-2 and iNOS in Microglial Cells

Won-Kyo Jung et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)

Add to Collection

Article Neurosciences

Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease

Anqi Qiu et al.

NEUROIMAGE (2009)

Add to Collection

Review Pharmacology & Pharmacy

The histamine H3 receptor:: an attractive target for the treatment of cognitive disorders

T. A. Esbenshade et al.

BRITISH JOURNAL OF PHARMACOLOGY (2008)

Add to Collection

Review Biochemistry & Molecular Biology

Understanding the molecular causes of Parkinson's disease

A. Wood-Kaczmar et al.

TRENDS IN MOLECULAR MEDICINE (2006)

Add to Collection

Article Biochemistry & Molecular Biology

Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo

FS Yang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Add to Collection

Article Neurosciences

Local neuroinflammation and the progression of Alzheimer's disease

PL McGeer et al.

JOURNAL OF NEUROVIROLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.